?> Contact us Follow Us
Biosimilars Forum
  • About Us
    • Members
    • Executive Director
  • Why Biosimilars
    • The Issue
    • Our Solutions
  • Biosimilars 101
    • Foundations
    • Core Principles
    • FDA Regulatory Tenets
    • Biosimilars FAQs
    • Future Evolution of Biosimilar Development
    • Approved Biosimilars
  • Advocacy
    • Our Action
    • Tools
  • News
  • Resources
  • Get Involved
    • Partners

News

Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
June 30, 2021 signalgroup
Biosimilars Forum Member Spotlight: 6 Questions for Coherus
News
June 24, 2021 signalgroup
Organon Joins Biosimilars Forum
News
June 21, 2021 signalgroup
Lowering Prices with Biosimilars: ASP+8: Stakeholder Meeting Round-Up
News
June 18, 2021 signalgroup
It’s time we fulfill the ACA’s promise to broaden access to lower-cost drugs
News
June 17, 2021 signalgroup
The Biosimilars Forum Applauds SCOTUS Decision to Uphold ACA and US Pathway for Biosimilar Approval
News
June 14, 2021 signalgroup
New Report Shows Biosimilars Significantly Lowered Prices of All Biologics
News
May 18, 2021 signalgroup
House Oversight Committee Spotlights Anticompetitive Practices Blocking Access to Lower Cost Biosimilars
News
April 30, 2021 signalgroup
Senators Cornyn and Bennet Introduce Bipartisan Legislation to Incentivize Biosimilars, Lower Cost for Seniors
News
April 28, 2021 signalgroup
Biosimilars Forum Calls for Bipartisan Policies That Lower Drug Prices on Expensive Biologics Ahead of President Biden’s Joint Session of Congress Address
News
April 27, 2021 signalgroup
Congressmen Tonko and Gibbs Introduce Bipartisan Legislation to Increase Transparency and Use of Biosimilars in Medicare Plans
  • Prev page
  • 06
  • 07
  • 08
  • 09
  • 10
  • Next page

  • Biosimilars 101
  • Biosimilars FAQs
  • Advocacy
  • Stay Connected
Biosimilars Forum
© 2025 Biosimilars Forum. All rights reserved.
  • Terms of Use
  • |
  • Privacy Policy
  • |
  • Contact Us